HIV TREATMENT
2020
Action 27. Mobilize their networks and work with communities to help build treatment literacy, generate demand, and expand access to ARVs among children.
Action 34. Increase efforts to share information on the roll-out of new paediatric formulations, including lessons learned.
Paediatric HIV & TB : Rome Action Plan
The Rome Action Plan is a compilation of commitments by key stakeholders to accelerate research, development, registration, introduction and uptake of HIV & TB diagnostics and medicines for children living with HIV and/or TB, as well as medicines for pregnant and lactating women, with the ultimate objective of reducing morbidity and mortality among these high vulnerable groups.
The Rome Action Plan is the product of a series of High Level Dialogues convened by the Vatican’s Dicastery for the Promotion of Integral Human Development (in 2016, 2018, 2020) and by the Pontifical Academy of Life (in 2022). The Dialogues are organized by the Elizabeth Glaser Pediatric AIDS Foundation (EGPAF), the World Health Organization (WHO), the President's Emergency Plan for AIDS Relief (PEPFAR), the Joint United Nations Programme on HIV/AIDS (UNAIDS), in collaboration with the Stop TB Partnership and faith-based organizations (FBOs) and global partner organizations.
EGPAF and WHO have the responsibility to monitor progress on the Action Plan and to promote full and timely implementation of the action points, including tracking progress towards milestones, and communicating regularly with participants about progress on their commitments and overall implementation of the Plan.
This website tracks the commitments of the Rome Action Plan.
​
​
High-Level Dialogue To Assess Progress on and Intensify Commitment To Scaling Up Prevention, Diagnosis and Treatment of
Paediatric HIV and TB
Vatican City | 5,6 and 7 December 2022
